# Chengda Biotechnology

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/chengda-biotechnology

- Industry: Biotechnology
- Headquarters: Shenyang, China
- Website: www.cdbio.cn
- Latest round: Series A (May 15, 2014)
- Investors on record: 3

## About

Established in 2002 and based in Liaoning, China, Chengda Biotechnology operates as a biotechnology company that focuses on rabies vaccine production. 

The company provides vaccine production. The product of the company includes human rabies vaccine, veterinary rabies vaccine and human JE inactivated vaccine.

## Funding rounds

- Series A, May 15, 2014 — New Alliance Capital
- Angel, Mar 1, 2010 — JD Capital, EBI Investment

## Investors

- JD Capital (https://capitalatlas.ai/funds/jd-capital) — Angel
- EBI Investment (https://capitalatlas.ai/funds/ebi-investment) — Angel
- New Alliance Capital (https://capitalatlas.ai/funds/new-alliance-capital) — Series A